LNTH  valuation analysis

Basics
Name: Lantheus Holdings, Inc
Description: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $1.73B (1103rd)
Sales(TTM): $341.21M (1279th)
Earnings(TTM): -$7.80M (1149th)

Value
FFER: 1.51*
Actual price: $25.68
* Earnings were reported Jul 28, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Lantheus Holdings, Inc's earnings decreased from $25.05M to -$7.80M in the last year.
  • Lantheus Holdings, Inc's operating income decreased from $42.62M to -$10.96M in the last year.
Earnings / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Book / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Equity / Assets
Lantheus Holdings, Inc
"Diagnostics & Research" industry